Target intelligence / Profile preview

Lymphocyte DNA

Molecular classification
Other
01

Overview

"Lymphocyte DNA" refers to the entire genomic DNA of lymphocytes, including all of the nuclear and mitochondrial DNA sequences contained within B, T, and NK cells. Unlike specific genes or proteins, lymphocyte DNA is not itself a discrete molecular target. However, the DNA of lymphocytes undergoes unique biological events, notably V(D)J recombination, which is essential for the generation of highly diverse antigen receptors (immunoglobulin in B cells and T-cell receptor in T cells)[1][3]. This process requires programmed DNA double-strand breaks and DNA repair, which integrate signaling pathways involving DNA damage response factors such as ATM kinase[1]. Aberration in these processes can contribute to diseases such as immunodeficiency, autoimmunity, and lymphoid cancers[1][3]. In mature lymphocytes, DNA can also be extruded as extracellular traps during immune activation, which has autocrine and paracrine signaling roles in immunity and inflammation[6]. However, "lymphocyte DNA" is not a standard term for a targetable molecule in drug development.

Other names
Lymphocyte genomic DNALymphocyte chromosomal DNADNA of lymphocytes
02

Biological functions

Genetic information storageTemplate for antigen receptor rearrangementCell differentiation and developmentDNA damage response
03

Disease associations

Cancer (e.g., lymphoid malignancies)Immunodeficiency (genetic disorders of DNA repair in lymphocytes)Autoimmune disease (via altered receptor diversity or DNA damage)Other (e.g., involvement in rare hereditary syndromes)
04

Safety considerations

Off-target genotoxicity in therapies that affect DNA (e.g., chemotherapy, radiation)Risk of chromosomal translocations from aberrant DNA processing in lymphocytes
05

Biomarkers

Immunoglobulin/T-cell receptor gene rearrangements (for clonality testing)DNA damage markers (e.g., γH2AX)Minimal residual disease markers in leukemia/lymphoma

Beyond the preview

Go deeper on Lymphocyte DNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lymphocyte DNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call